RxDoctor Payments DataLook up a doctor →

Heather Popham, NP

Adult Health · Saint Louis, MONPI 1093086985

Payments from drug & device makers

$10,150in general payments, 2019–2025

Across 492 payments — averaging $20.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Novartis$645
  • Teva Pharmaceuticals USA, Inc.$600
  • SK Life Science, Inc.$587
  • Neurocrine Biosciences, Inc.$571
  • UCB, Inc.$439
  • plus $5K from 43 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie115$2,582
Novartis36$645
Teva Pharmaceuticals USA, Inc.35$600
SK Life Science, Inc.12$587
Neurocrine Biosciences, Inc.27$571
UCB, Inc.21$439
Lundbeck LLC21$374
Alkermes, Inc.16$308
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)14$282
Biogen14$276
Eisai Inc.11$276
Amgen13$272
Biohaven Pharmaceuticals, Inc.13$223
Kyowa Kirin, Inc.8$221
Pfizer20$199
EMD Serono, Inc.11$195
E.r. Squibb & Sons, L.L.C.3$174
Takeda Pharmaceuticals U.S.A., Inc.9$155
TG Therapeutics, Inc.4$140
Bristol Myers Squibb6$135
Neurelis, Inc.6$120
Lilly USA, LLC7$112
Genentech USA, Inc.5$103
AstraZeneca(2 entities)5$86
Sunovion Pharmaceuticals Inc.7$85
Acorda Therapeutics, Inc4$83
Amneal Pharmaceuticals LLC4$83
Neos Therapeutics, LP4$76
Grifols USA, LLC4$76
Sanofi4$73
Argenx US, Inc.3$73
Tanabe Pharma America, Inc.4$67
Johnson & Johnson3$57
Otsuka America Pharmaceutical, Inc.3$54
Corium, LLC3$42
Axsome Therapeutics, Inc.2$31
Avion Pharmaceuticals2$31
Haemonetics Corporation1$31
Avanir Pharmaceuticals, Inc.2$25
Springworks Therapeutics, Inc.1$24
Sumitomo Pharma America, Inc.1$23
Impel Pharmaceuticals Inc.1$22
Collegium Pharmaceutical, Inc.1$19
Upsher-smith Laboratories LLC1$19
Jazz Pharmaceuticals Inc.1$19
Octapharma USA, Inc.1$18
Supernus Pharmaceuticals, Inc.1$17
Noven Therapeutics, LLC1$16
Almatica Pharma LLC1$13

How this compares

$10,150 in reported general payments places this provider in the 95th percentile of 555 adult health providers in Missouri.

See all adult health providers in Missouri →

Medicare billing

Part B allowed, 2024
$42,201
Medicare patients
256
Services billed
443

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Saint Louis

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →